Christophe Bernard.

Christophe Bernard

Director of research
Institute of Systems Neuroscience

Christophe Bernard is director of research at the Institute of Systems Neuroscience, INSERM U1106. His main interest is to understand brain dynamics in health and disease, with a focus on epilepsy.

He acts as a reviewing editor for Science Advances, and formerly for Science and the Journal of Neuroscience. He created and is the editor-in-chief of eNeuro, the online open-access journal of the Society for Neuroscience. eNeuro is designed to serve and educate the neuroscience community, promoting reproducibility, publishing negative results and sensitizing scientists to open science and better data interpretation with a focus on statistics and experimental bias.

Bernard obtained his Ph.D. in neuroscience from Pierre and Marie Curie University, did his postdoctoral research at the University of Southampton and spent a sabbatical at Baylor College of Medicine. He participated in the development of organic technologies to record and control brain activity, which earned him the Felix Innovation Prize, and in the development of the Virtual Mouse Brain.

Explore more from The Transmitter

Image of squirrels on a branch.

NeuroAI and the hidden complexity of agency

As we attempt to build autonomous artificial-intelligence systems, we're discovering that a capability we take for granted in animals may be much more complex than we imagined.

By Anthony Zador
5 February 2025 | 6 min read

Plaque levels differ in popular Alzheimer’s mouse model depending on which parent’s variants are passed down

5XFAD model mice that inherit two disease-related genes from their fathers have double the plaques seen in those with maternal inheritance, a new study shows.

By Shaena Montanari
4 February 2025 | 0 min watch
The word Doctored spelled out on pills.

‘Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,’ an excerpt

In his new book, published today, investigative journalist Charles Piller tells the story of the scientific misconduct that shook Alzheimer’s disease research to its core, and the neuroscientist who helped to expose it.

By Charles Piller
4 February 2025 | 9 min read